The Healthcare Inflection Point: AI Can’t Fix 1990s Technology
Isolated improvements rarely translate into enterprise-wide transformation when they are layered onto outdated, inefficient workflows…
The Healthcare Inflection Point: AI Can’t Fix 1990s Technology
Isolated improvements rarely translate into enterprise-wide transformation when they are layered onto outdated, inefficient workflows instead of being integrated into redesigned care delivery. The post The Healthcare Inflection Point: AI Can’t Fix 1990s Technology appeared first on MedCity News.
The Pandemic Risk of “What I’ve Never Seen Before”
By MIKE MAGEE The world of medical science largely closed ranks last month in defense of Tony Fauci. Dr. Fauci had been hauled before the Senate Homeland Security Committee to face hostile entrapment by long time critique Senator Rand Paul of Kentucky. Taking no chances, his lawyers had the former head of NIH’s Infectious Disease…
This Merger Wants to Prevent Rare Disease Patients from Losing Their Data
Cushla and Clirinx, two Irish startups, are merging to give rare disease patients one continuous health and research record. The deal will pair Cushla’s patient-controlled EHR with Clirinx’s unique patient ID system so data no longer gets lost between doctors, hospitals and clinical trials. The post This Merger Wants to Prevent Rare Disease Patients from…
HHS Provides $77M in Grants for Substance Use Prevention, Mental Health
HHS awarded $77 million in SAMHSA grants for substance use prevention and treatment, mental health, suicide prevention and crisis services. The post HHS Provides $77M in Grants for Substance Use Prevention, Mental Health appeared first on MedCity News.
GSK’s Pivotal Test for mRNA Flu Vaccine Aims to Show Two Targets Are Better Than One
GSK’s messenger RNA vaccine for seasonal influenza is designed to prompt an immune response to two proteins on the surface of the virus. That could be an advantage over Moderna’s recently approved mRNA flu shot, which addresses just one of those proteins. The post GSK’s Pivotal Test for mRNA Flu Vaccine Aims to Show Two…
Breaking the Amendment Cycle: How Agentic AI Enables Smarter Clinical Trial Design and Operations
Faster trials are not a vanity metric. They reflect an undeniable need: getting safe therapies to patients sooner. The post Breaking the Amendment Cycle: How Agentic AI Enables Smarter Clinical Trial Design and Operations appeared first on MedCity News.
“We’re Sorry, That’s the Policy”: How a Medicare Advantage Runaround Nearly Cost a Senior His Sight
By FRANK LEAHY On a gray February morning, I sat in my office in Inverness, in rural northern California, with the phone pressed to my ear, jotting down notes and Humana reference numbers. Across the table, my new friend Rick, 77, waited anxiously, struggling to follow the conversation. Nearly deaf and now partially blind, Rick…
Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs
August has seen a slew of executive hires, exits and layoffs across the healthcare industry. For instance, Humana, Merck and Mayo Clinic named new executives. There were also layoffs at organizations including MaineHealth, Cellares and Sharp HealthCare. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first on MedCity News.
MedCity FemFwd: How Midwives Can Support the Maternal Health Crisis
In this episode, we’re joined by Amanda Shafton, practicing CNM and national director of midwifery at Ob Hospitalist Group. We discuss the benefits of physician/midwifery collaboration and how midwives can improve maternal health outcomes. The post MedCity FemFwd: How Midwives Can Support the Maternal Health Crisis appeared first on MedCity News.
4 Notable Health Tech Funding Announcements in August
Health tech companies made several major funding announcements in August. Here is a list of some of the biggest funding rounds. The post 4 Notable Health Tech Funding Announcements in August appeared first on MedCity News.
